Ranbaxy tanks after Daiichi blames former shareholders for $500 mn fine

Ranbaxy Laboratories slumped as much as 6.6 per cent on Thursday after majority shareholder Daiichi Sankyo said it believes former shareholders of the Indian company hid information regarding U.S. regulatory probes. "Daiichi Sankyo believes that certain former shareholders of Ranbaxy concealed and misrepresented critical information concerning the U.S. DOJ and FDA investigations," the Japanese company said in a statement on its ...